EP2884999
AÐFERÐ OG EFNASAMSETNINGAR TIL ÓNÆMINGAR Í FRUMUM
Status:
EP einkaleyfi: Endurútgefin þýðing EP einkaleyfisEP appl. date:
20.8.2013EP published:
4.11.2020EP application number:
13753495.4
EP translation filed:
7.1.2021Grant published:
15.2.2021EPO information:
European Patent Register
Max expiry date:
19.8.2033Expiry date:
19.8.2026Next due date:
31.8.2026
Title:
METHOD AND COMPOSITIONS FOR CELLULAR IMMUNOTHERAPY
Timeline
Today
20.8.2013EP application
4.11.2020EP Publication
7.1.2021Translation submitted
15.2.2021Registration published
19.8.2026Expires
Owner
Name:
Seattle Children's Hospital, dba Seattle Children's Research InstituteAddress:
1900 9th Avenue, Seattle, WA 98101, US
Name:
Fred Hutchinson Cancer CenterAddress:
1100 Fairview Avenue North, 98109, Seattle, WA, US
Inventor
Name:
RIDDELL, Stanley, R.Address:
Sammamish, WA 98075, US
Name:
HUDECEK, MichaelAddress:
04107 Leipzig, DE
Name:
JENSEN, MichaelAddress:
Bainbridge Island, WA 98110, US
Agent
Name:
Zacco Denmark A/SAddress:
Arne Jacobsens Allé 15, DK
Priority
Number:
201261691117 PDate:
20.8.2012Country:
US
Classification
Categories:
C07K 14/725, C07K 16/28, C07K 16/32, C07K 14/715, C07K 14/705
Annual fees
Number
Paid
Expires
Payer
Number: 9
Paid: 30.7.2021
Expires: 19.8.2022
Payer: Sigurjónsson & Thor ehf.
Number: 10
Paid: 2.8.2022
Expires: 19.8.2023
Payer: Patice ehf.
Number: 11
Paid: 3.8.2023
Expires: 19.8.2024
Payer: Árnason Faktor ehf.
Number: 12
Paid: 7.8.2024
Expires: 19.8.2025
Payer: Árnason Faktor ehf.
Number: 13
Paid: 13.8.2025
Expires: 19.8.2026
Payer: Árnason Faktor ehf.